Approval · Notice of Compliance 29209 · 2022
ILLUCCIX: Notice of Compliance 29209
Issued October 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29209
- Date
- October 13, 2022
- Company
- Telix Pharmaceuticals (Us) IncFishers, Indiana, United States
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ILLUCCIX | 02531836 | Marketed |
Medicinal ingredients
- GALLIUM (68GA) GOZETOTIDE 25 MCG per VIAL